Sustainability Discussion: The Impact of Clinical Trials on the Global Climate Crisis and the Imperative for Timely Change
Tuesday, May 14, 2024, 11:15 AM - 12:00 PM
Addressing the pressing environmental impact of clinical trial execution is crucial for sustainable development. Recognizing the need for low-carbon clinical trials is a positive step toward mitigating the industry's contribution to climate change. In this session, we will examine the progress the industry has made in recent years and strategies for conducting low carbon clinical trials.
• Michael J Cohen, MSc, MBA - Senior Director, Environmental Sustainability | Digital and Decentralized Solutions - PPD (Facilitator)
• Neil Mackillop - Senior Medical Director Global Clinical Development - AstraZeneca (Panelist)
• Carly Santer, PhD - Strategic Initiatives Project Leader & Sustainability Activator - Bayer (Panelist)
• Jürgen Wieland - Development Environmental Sustainability Lead - Novartis Pharma AG, Basel (Panelist)
• Neil Mackillop - Senior Medical Director Global Clinical Development - AstraZeneca (Panelist)
• Carly Santer, PhD - Strategic Initiatives Project Leader & Sustainability Activator - Bayer (Panelist)
• Jürgen Wieland - Development Environmental Sustainability Lead - Novartis Pharma AG, Basel (Panelist)